Stay updated on Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.

Latest updates to the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays a minor revision label (v3.4.2) replacing the previous v3.4.1; no study content, eligibility criteria, or locations are changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page footer shows a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded UI elements and metadata label changes, including a glossary toggle (Show glossary) and updates to QC-related fields such as Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedA minor metadata update shows Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedA new Locations section lists study sites across multiple U.S. states and Hordaland, Norway. The revision tag updated to v3.3.3.SummaryDifference1%

Stay in the know with updates to Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.